ヘルスケアBPO市場規模、シェア、動向、2031年までの世界予測

Healthcare BPO Market - Global Forecast to 2031

ヘルスケアBPO市場 - ライフサイエンス（創薬、臨床試験、規制対応）、医療提供者（RCM、臨床文書作成、患者エンゲージメント）、医療保険者（請求・支払管理）、テクノロジー（BPaaS、AI活用型）、モデル（オンショア、オフショア） - 2031年までの世界市場予測

Healthcare BPO Market by Life Science (Drug Discovery, Clinical Trial, Regulatory), Provider (RCM, Clinical Documentation, Patient Engagement), Payer (Billing, Claims), Technology (BPaaS, AI-enabled), Model (Onshore, Offshore) - Global Forecast to 2031

出版	MarketsandMarkets
出版年月	2026年07月
ページ数	457
図表数	592
価格	記載以外のライセンスについてはお問合せください
シングルユーザ	USD 4,950
種別	英文調査報告書
商品番号	SMR-26710

世界のヘルスケアBPO市場は、2026年の4,598億3,000万米ドルから、年平均成長率（CAGR）9.8%で推移し、2031年には7,350億5,000万米ドルに達するとMarketsandMarketsでは予測しています。市場の成長は、医療保険者（ペイアー）、医療提供者（プロバイダー）、およびライフサイエンス企業の各業務プロセスにおける運営上の負荷を軽減する必要性によって牽引されています。医療関連組織は、請求管理、加入者登録、医療提供者ネットワーク管理、支払適正化（ペイメント・インテグリティ）、収益サイクル管理（RCM）、医療コーディング、患者サポート、臨床データ管理、医薬品安全性監視（ファーマコビジランス）、薬事関連業務、商用化支援といった業務を外部委託しています。医療保険者は、請求の正確性向上、不正請求や不適切支払いの削減、医療提供者データの管理、加入者サービスの強化を図るためにBPOパートナーを活用しています。

医療提供者は、キャッシュフローの改善や事務作業の負担軽減を目的に、RCM、請求却下（デナイアル）管理、コーディング、文書作成、患者向けコンタクトセンター業務などを外部委託しています。ライフサイエンス企業は、臨床開発、安全性報告、製造支援、サプライチェーン、薬事関連業務において、外部委託パートナーへの依存を強めています。これらの業務には、専門的な知見、コンプライアンスに関する知識、そしてグローバルな提供体制が必要とされるためです。さらに、コスト削減や処理時間の短縮に寄与する自動化、AIを活用したコーディング、分析主導型の支払適正化、プラットフォーム型BPaaS、オフショア提供モデルといった要素も、市場の成長を後押ししています。

調査対象範囲

本調査レポートでは、ヘルスケアBPO市場を以下の区分で分類しています。サービス別：ライフサイエンス関連サービス（研究・臨床開発［創薬・前臨床、臨床試験管理、臨床データ・生物統計、RWE・後期開発、その他R&D支援］、製造・包装、サプライチェーン・物流、商業化・メディカルアフェアーズ、安全性・規制・品質、その他）、ペイアー（保険者）関連サービス（加入者登録・請求、医療提供者ネットワーク管理、請求管理［請求受付・データ入力、請求審査・決済、請求内容編集、価格設定・再設定、請求調整、不払い・再処理、請求支払・送金支援］、支払適正化、加入者・医療提供者サポート、その他）、および医療提供者関連サービス（収益サイクル管理［フロントエンドRCM、ミッドサイクルRCM、バックエンドRCM］、医療情報管理・臨床文書作成［臨床文書改善、医療事務・文書作成サービス、診療録管理・情報開示］、患者エンゲージメント・コンタクトセンターサービス［患者コンタクトセンター・コミュニケーションサービス、患者向け財務カウンセリング・支援、退院後フォローアップ・ケアナビゲーション］、臨床支援サービス［遠隔放射線診断・遠隔画像診断サービス、遠隔患者モニタリングデータ管理、集団健康管理・ケア調整支援］、非臨床的業務支援サービス、その他）。また、本レポートでは、技術モデル（従来のBPO、自動化対応BPO、プラットフォーム型BPaaS、AI活用型BPO）、サービス提供モデル（オンショア、オフショア、ハイブリッド／マルチショア）、および地域（北米、欧州、アジア太平洋、中南米、中東・アフリカ）別にも市場を分類しています。

本レポートでは、ヘルスケアBPO市場の成長に影響を与える主要因（促進要因、抑制要因、課題、機会など）に関する詳細情報を提供しています。主要な業界プレーヤーについて詳細な分析を行い、事業概要、サービスポートフォリオ、技術力、主要戦略、契約・提携・合意事項、サービス開始、M&A、およびヘルスケアBPO市場に関連する最近の動向についての知見を提供します。さらに、ヘルスケアBPOエコシステムにおける既存企業および新興企業の競合分析も行っています。

本レポートを購入すべき理由

本レポートは、ヘルスケアBPO市場およびそのサブセグメントにおける収益規模の推定値を、市場の主要企業や新規参入企業に提供します。これにより、ステークホルダーは競争環境を把握し、自社の事業をより効果的に位置づけ、適切な市場参入戦略を策定するための知見を得ることができます。また、市場の動向を理解する一助となるほか、市場を牽引する要因（ドライバー）、阻害要因、課題、および機会に関する情報も提供します。

本レポートでは、以下の点に関する知見を提供します。

ヘルスケアBPO市場の成長に影響を与える以下の要因について解説します：成長要因（ICD-10コーディング基準への移行および次期ICD-11基準の導入、増大する医療費の削減圧力、請求ミスによる収益損失、ニッチなサービスへの需要、プロセスや文書化の体系化の必要性、利用業界における社内専門知識の不足、製薬・バイオ医薬品業界でのアウトソーシング拡大）、阻害要因（アウトソーシングに伴う隠れたコスト、業務プロセスに対する可視性や管理権限の喪失への懸念）、機会（高度なデータ分析、創薬におけるAI活用ツールの導入拡大）、および課題（メディケイド（Medicaid）サービスにおけるデータ収集プロセスの制約、データセキュリティへの懸念）。

製品開発・イノベーション：ヘルスケアBPO市場における次世代技術、研究開発（R&D）活動、および新製品・新サービスの投入に関する詳細な知見
市場開拓：有望な市場に関する包括的な情報（本レポートでは、様々な地域におけるヘルスケアBPO市場を分析）
市場の多角化：ヘルスケアBPO市場における新製品・新サービス、未開拓地域、最近の動向、および投資に関する網羅的な情報
競合分析：Optum, Inc.（米国）、Tata Consultancy Services Limited（インド）、Accenture plc（アイルランド）、Cognizant（米国）、Infosys Limited（インド）、IQVIA Holdings Inc.（米国）など、ヘルスケアBPO市場の主要企業に関する市場シェア、成長戦略、および提供サービスについての詳細な分析

Report Description

The global healthcare BPO market is projected to reach USD 735.05 billion by 2031, up from USD 459.83 billion in 2026, at a CAGR of 9.8%. Market growth is driven by the need to reduce operational pressure across payer, provider, and life sciences workflows. Healthcare organizations are outsourcing processes such as claims administration, member enrollment, provider network management, payment integrity, revenue cycle management, medical coding, patient support, clinical data management, pharmacovigilance, regulatory affairs, and commercialization support. Payers are using BPO partners to improve claims accuracy, reduce fraud and improper payments, manage provider data, and enhance member service. Providers are outsourcing RCM, denial management, coding, documentation, and patient contact center operations to improve cash flow and reduce administrative workload. Life sciences companies are increasingly relying on outsourcing partners for clinical development, safety reporting, manufacturing support, supply chain, and regulatory operations because these activities require specialized expertise, compliance knowledge, and global delivery scale. The market is further supported by automation, AI-enabled coding, analytics-driven payment integrity, platform-based BPaaS, and offshore delivery models that help reduce costs and improve turnaround time.

ヘルスケアBPO市場規模、シェア、動向、2031年までの世界予測 - by service

Healthcare BPO Market – Global Forecast to 2031 – by service

“Manufacturing & packaging accounted for the largest share of the life science services segment in 2025”

Within life sciences services, the healthcare BPO market is segmented into research & clinical development, manufacturing & packaging, supply chain & logistics, commercialization and medical affairs, safety, regulatory & quality, and others. The manufacturing & packaging segment accounted for the largest share in 2025, as pharmaceutical, biotechnology, and medical device companies continue to outsource high-value production and packaging to specialized partners. This segment includes drug substance manufacturing, drug product manufacturing, biologics manufacturing, sterile fill-finish, device assembly, clinical and commercial packaging, labeling, and serialization. Outsourcing is especially important because life sciences companies need scalable manufacturing capacity, strict quality compliance, sterile production capabilities, and packaging support for regulated products.

“Payment integrity is expected to witness the fastest growth in payer services during the forecast period”

Based on payer services, the healthcare BPO market is segmented into member enrollment & billing, provider network management, claims administration, payment integrity, member & provider support, and others. Among these segments, payment integrity is expected to grow fastest over the forecast period. This growth is driven by the need to reduce improper payments, billing errors, duplicate claims, coding issues, fraud, waste, and abuse across payer operations. Payment integrity services include pre-payment review, post-payment audit, overpayment recovery, coordination of benefits, subrogation, claims coding review, clinical review, and fraud analytics. Payers are increasingly turning to outsourcing partners because claim rules, reimbursement contracts, provider billing patterns, and regulatory requirements are becoming more complex. As healthcare costs continue to rise, payment integrity is becoming a priority for health plans to protect margins, improve claims accuracy, and reduce avoidable medical spending.

Healthcare BPO Market – Global Forecast to 2031 – by region

“Asia Pacific to witness the fastest growth in the healthcare BPO market during the forecast period”

Asia Pacific is expected to see the highest growth rate in the healthcare BPO market over the forecast period. This growth is driven by rising healthcare digitization, expanding private healthcare networks, broader insurance coverage, and increased outsourcing of payer, provider, and life sciences processes. Countries such as India, China, Japan, South Korea, Australia, and the Philippines are becoming important markets as healthcare organizations seek to manage higher patient volumes, reduce administrative workloads, and improve claims, billing, medical coding, clinical data, and patient support operations. India’s Ayushman Bharat Digital Mission is also building the digital infrastructure needed for connected health records and digital healthcare workflows, which can increase demand for technology-enabled outsourcing over time. Asia Pacific is also a strong delivery hub for healthcare BPO because of its large skilled workforce, cost-efficient operations, English-language support, and established outsourcing infrastructure. The Philippines IT-BPM industry was expected to reach USD 38 billion in revenue and 1.82 million jobs in 2024, according to Reuters in October 2024, underscoring the region’s strong outsourcing base. In life sciences.

The breakdown of primary participants is as given below:

By Company Type – Tier 1: 60%, Tier 2: 30%, and Tier 3: 10%
By Designation – C-level: 30%, Director-level: 50%, and Others: 20%
By Region – North America: 45%, Europe: 20%, Asia Pacific: 25%, Rest of the world: 10%.

Optum, Inc. (US), Tata Consultancy Services Limited (India), Accenture plc (Ireland), Cognizant (US), Infosys Limited (India), IQVIA Holdings Inc. (US) are some of the key players in the healthcare BPO market.

Healthcare BPO Market – Global Forecast to 2031 – by ecosystem

The study includes an in-depth competitive analysis of these key players in the healthcare BPO market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the healthcare BPO market by Services: Life Sciences Services [Research & Clinical Development {Discovery & Preclinical, Clinical Trial Management, Clinical Data & Biostatistics, RWE & Late-Phase, Other R&D Support}, Manufacturing & Packaging, Supply Chain & Logistics, Commercialization and Medical Affairs, Safety, Regulatory & Quality, Others], Payer Services [Member Enrollment & Billing, Provider Network Management, Claims Administration {Claims Intake & Data Capture, Claims Adjudication & Settlement, Claims Editing, Pricing & Repricing, Claims Adjustment, Denials & Rework, Claims Payment & Remittance Support}, Payment Integrity, Member & Provider Support, Others], and Provider Services [Revenue Cycle Management {Front-end RCM, Mid-cycle RCM, Back-end RCM}, Health Information Management and Clinical Documentation {Clinical Documentation Improvement, Medical Transcription and Clinical Documentation Services, Medical Records Management and Release of Information}, Patient Engagement and Contact Center Services {Patient Contact Center and Communication Services, Patient Financial Counseling and Assistance, Post-discharge Follow-up and Care Navigation}, Clinical Support Services {Teleradiology and Remote Diagnostic Imaging Services, Remote Patient Monitoring Data Management, Population Health Outreach and Care Coordination Support}, Non-Clinical Administrative Support Services, Others]. The report also categorizes the market by Technology Model [Traditional BPO, Automation-enabled BPO, Platform-based BPaaS, AI-enabled BPO], Service Delivery Model [Onshore, Offshore, Hybrid/Multishore], and Region [North America, Europe, Asia Pacific, Latin America, and Middle East & Africa].

The report provides detailed information on major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the healthcare BPO market. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, service portfolios, technological capabilities, key strategies, contracts, partnerships, agreements, service launches, mergers & acquisitions, and recent developments associated with the healthcare BPO market. The report also covers a competitive analysis of established and emerging players in the healthcare BPO ecosystem.

Reasons to buy this report

The report will provide market leaders and new entrants with the closest approximations of revenue figures for the healthcare BPO market and its subsegments. It will help stakeholders understand the competitive landscape and gain insights to position their businesses more effectively and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

The report provides insights into the following factors influencing the growth of the healthcare BPO market: drivers (shift to ICD-10 coding standards and the upcoming ICD-11 standard, pressure to reduce rising healthcare costs, loss of revenue due to billing errors, demand for niche services, need for structured processes and documentation, lack of in-house expertise in end-use industries, and growing outsourcing in the pharma and biopharma industries), restraints (hidden outsourcing costs and concerns about losing visibility and control over business processes), opportunities (advanced data analytics and growing adoption of artificial intelligence-based tools for drug discovery), and challenges (limitations in the data capture process in Medicaid services and data security concerns).

Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product & service launches in the healthcare BPO market
Market Development: Comprehensive information about lucrative markets; the report analyzes the healthcare BPO market across varied regions
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare BPO market
Competitive Assessment: In-depth assessment of market share, growth strategies, and service offerings of leading players such as Optum, Inc. (US), Tata Consultancy Services Limited (India), Accenture plc (Ireland), Cognizant (US), Infosys Limited (India), IQVIA Holdings Inc. (US), among others, in the healthcare BPO market.

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.3 STUDY SCOPE 41
1.3.1 MARKET SEGMENTATION 41
1.3.2 REGIONAL SCOPE 42
1.3.3 INCLUSIONS AND EXCLUSIONS 42
1.3.4 YEARS CONSIDERED 44
1.4 CURRENCY CONSIDERED 44
1.5 LIMITATIONS 45
1.6 STAKEHOLDERS 45
1.7 SUMMARY OF CHANGES 46
2 EXECUTIVE SUMMARY 47
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 47
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 49
2.3 DISRUPTIVE TRENDS IN HEALTHCARE BPO MARKET 50
2.4 HIGH-GROWTH SEGMENTS 51
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 52
3 PREMIUM INSIGHTS 53
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE BPO MARKET 53
3.2 HEALTHCARE BPO MARKET, BY SERVICE AND REGION 54
3.3 HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL 54
3.4 HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL 55
3.5 HEALTHCARE BPO MARKET, BY GEOGRAPHY 55
4 MARKET OVERVIEW 56
4.1 INTRODUCTION 56
4.2 MARKET DYNAMICS 56
4.2.1 DRIVERS 57
4.2.1.1 Widespread ICD-10 adoption and transition to ICD-11 coding standards 57
4.2.1.2 Rising need to cut healthcare costs while improving operational efficiency 58
4.2.1.3 Growing concern about billing errors, coding inaccuracies, and claim denials 59
4.2.1.4 Mounting demand for value-based care and evolving reimbursement models 59
4.2.1.5 Rising emphasis on structured processes and documentation 60
4.2.1.6 Increasing healthcare operation complexity and specialized professional shortage 60
4.2.1.7 Strong focus on improving efficiency and safety in pharma and biopharma industries 61
4.2.2 RESTRAINTS 62
4.2.2.1 Implementation and governance cost burden 62
4.2.2.2 Concerns related to visibility and control over business processes 62
4.2.3 OPPORTUNITIES 63
4.2.3.1 Reliance on advanced data analytics 63
4.2.3.2 Rise in adoption of AI-based tools for drug discovery 64
4.2.4 CHALLENGES 64
4.2.4.1 Limitations in data capturing process in Medicaid services 64
4.2.4.2 Data security concerns 65
4.3 UNMET NEEDS AND WHITE SPACES 66
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 67
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 68
5 INDUSTRY TRENDS 69
5.1 PORTER’S FIVE FORCES ANALYSIS 69
5.1.1 THREAT OF NEW ENTRANTS 70
5.1.2 THREAT OF SUBSTITUTES 70
5.1.3 BARGAINING POWER OF SUPPLIERS 71
5.1.4 BARGAINING POWER OF BUYERS 71
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 71
5.2 MACROECONOMICS OUTLOOK 72
5.2.1 INTRODUCTION 72
5.2.2 GDP TRENDS AND FORECAST 72
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 72
5.2.4 TRENDS IN GLOBAL BUSINESS PROCESS OUTSOURCING INDUSTRY 73
5.3 SUPPLY CHAIN ANALYSIS 73
5.4 ECOSYSTEM ANALYSIS 75
5.5 PRICING ANALYSIS 76
5.5.1 INDICATIVE PRICE OF HEALTHCARE BPO SERVICES, BY SERVICE TYPE, 2025 76
5.5.2 INDICATIVE PRICE OF HEALTHCARE BPO SERVICES, BY REGION, 2025 77
5.6 KEY CONFERENCES AND EVENTS, 2026–2027 78
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 79
5.8 INVESTMENT AND FUNDING SCENARIO 80
5.9 CASE STUDY ANALYSIS 81
5.9.1 BIOPHARMACEUTICAL COMPANY IN US LEVERAGES CANON BUSINESS PROCESS SERVICES’ ACCOUNTS PAYABLE OUTSOURCING SOLUTIONS TO OPTIMIZE END-TO-END INVOICE PROCESSING 81
5.9.2 PHARMACEUTICAL COMPANY IN US RELIES ON C3I SOLUTIONS’ MEDICAL INFORMATION OUTSOURCING SERVICES TO OPTIMIZE COST AND EFFICIENCIES 82
5.9.3 RADIOLOGISTS IN AUSTRALIA ADOPT FLATWORLD SOLUTIONS’ TRANSCRIPTION AUTOMATION OUTSOURCING SERVICES TO FOCUS
ON PATIENT CARE 83
5.10 IMPACT OF US TARIFFS – HEALTHCARE BPO MARKET 84
5.10.1 INTRODUCTION 84
5.10.2 KEY TARIFF RATES 84
5.10.3 PRICE IMPACT ANALYSIS 85
5.10.4 IMPACT ON COUNTRIES/REGIONS 85
5.10.4.1 US 85
5.10.4.2 Europe 86
5.10.4.3 Asia Pacific 86
5.11 IMPACT ON END USERS 87
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 88
6.1 KEY EMERGING TECHNOLOGIES 88
6.1.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 88
6.1.2 ROBOTIC PROCESS AUTOMATION 88
6.1.3 CLOUD COMPUTING 89
6.2 COMPLEMENTARY TECHNOLOGIES 89
6.2.1 WEARABLE DEVICES AND REMOTE MONITORING TOOLS 89
6.2.2 AUGMENTED REALITY AND VIRTUAL REALITY 90
6.2.3 DATA ANALYTICS AND BUSINESS INTELLIGENCE 90
6.3 ADJACENT TECHNOLOGIES 90
6.3.1 NATURAL LANGUAGE PROCESSING 90
6.3.2 INTERNET OF MEDICAL THINGS 91
6.3.3 BLOCKCHAIN 91
6.4 TECHNOLOGY/PRODUCT ROADMAP 92
6.5 PATENT ANALYSIS 92
6.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE BPO 92
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 93
6.6 FUTURE APPLICATIONS 96
6.6.1 AGENTIC AI AND AUTONOMOUS HEALTHCARE OPERATIONS 96
6.6.2 PREDICTIVE POPULATION HEALTH AND PERSONALIZED PATIENT ENGAGEMENT 96
6.6.3 REAL-WORLD DATA AND LIFE SCIENCES SUPPORT SERVICES 96
6.7 IMPACT OF AI/GEN AI ON HEALTHCARE BPO MARKET 97
6.7.1 TOP USE CASES AND MARKET POTENTIAL 98
6.7.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN HEALTHCARE BPO MARKET 100
6.7.3 INTERCONNECTED ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 101

6.7.4 CLIENTS’ READINESS TO ADOPT AI/GEN AI IN HEALTHCARE BPO MARKET 102
6.7.4.1 User readiness 102
6.7.4.1.1 User A: Healthcare payers (health plans & insurance companies) 102
6.7.4.1.2 User B: Healthcare providers (hospitals, health systems & physician groups) 102
6.7.4.2 Impact assessment 103
6.7.4.2.1 User A 103
6.7.4.2.1.1 Implementation 103
6.7.4.2.1.2 Impact 103
6.7.4.2.2 User B 103
6.7.4.2.2.1 Implementation 103
6.7.4.2.2.2 Impact 103
6.7.5 BEST PRACTICES FOLLOWED BY COMPANIES IN HEALTHCARE BPO MARKET 104
7 REGULATORY LANDSCAPE 105
7.1 REGIONAL REGULATIONS AND COMPLIANCE 105
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105
7.1.2 REGULATIONS 108
7.1.3 INDUSTRY STANDARDS 110
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 111
8.1 INTRODUCTION 111
8.2 DECISION-MAKING PROCESS 111
8.3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AND EVALUATION CRITERIA 112
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 112
8.3.2 BUYING CRITERIA 113
8.4 ADOPTION BARRIERS AND INTERNAL CHALLENGES 114
8.5 UNMET NEEDS OF VARIOUS END USERS 114
8.5.1 UNMET NEEDS 114
8.5.2 END USERS’ EXPECTATIONS 115
8.6 MARKET PROFITABILITY 117
9 HEALTHCARE BPO MARKET, BY SERVICE 118
9.1 INTRODUCTION 119
9.2 LIFE SCIENCES SERVICES 119
9.2.1 RESEARCH & CLINICAL DEVELOPMENT 121
9.2.1.1 Discovery & preclinical 122
9.2.1.1.1 Growing demand for specialized capabilities and operational agility to foster segmental growth 122
9.2.1.2 Clinical trial management 123
9.2.1.2.1 Rising operational complexity of decentralized and hybrid trial models to augment segmental growth 123
9.2.1.3 Clinical data & biostatistics 124
9.2.1.3.1 High emphasis on data quality, regulatory compliance, and risk-based quality management to expedite segmental growth 124
9.2.1.4 RWE & late-phase 125
9.2.1.4.1 Growing focus on meeting evolving regulatory, market access, and reimbursement requirements to fuel segmental growth 125
9.2.1.5 Other R&D services 126
9.2.2 MANUFACTURING & PACKAGING 127
9.2.2.1 Mounting demand for biologics, GLP-1 therapies, cell and gene therapies, and other complex biopharmaceutical products to drive market 127
9.2.3 SUPPLY CHAIN & LOGISTICS 128
9.2.3.1 Rising real-time data exchange and electronic drug traceability requirements to contribute to segmental growth 128
9.2.4 COMMERCIALIZATION & MEDICAL AFFAIRS 129
9.2.4.1 Increasing complexity of pricing, reimbursement, health economics, and value-based healthcare to boost segmental growth 129
9.2.5 SAFETY, REGULATORY & QUALITY 130
9.2.5.1 Growing volume of adverse event and post-marketing surveillance obligations to accelerate segmental growth 130
9.2.6 OTHER LIFE SCIENCES SERVICES 131
9.3 PAYER SERVICES 132
9.3.1 MEMBER ENROLLMENT & BILLING 133
9.3.1.1 Rapid expansion of health plans, frequent eligibility redeterminations, and changing member coverage to drive market 133
9.3.2 PROVIDER NETWORK MANAGEMENT 134
9.3.2.1 Stricter network adequacy and directory accuracy standards to bolster segmental growth 134
9.3.3 CLAIMS ADMINISTRATION 135
9.3.3.1 Claims intake & data capture 136
9.3.3.1.1 Mounting adoption of digital technologies to improve data accuracy to expedite segmental growth 136
9.3.3.2 Claims adjudication & settlement 137
9.3.3.2.1 Increasing complexity of reimbursement policies to create market growth opportunities 137
9.3.3.3 Claims editing, pricing & repricing 138
9.3.3.3.1 Rising deployment of technology-enabled solutions to streamline processes to foster segmental growth 138
9.3.3.4 Claims adjustment, denials & rework 139
9.3.3.4.1 Evolving reimbursement policies and increasing regulatory requirements to augment segmental growth 139
9.3.3.5 Claims payment & remittance support 139
9.3.3.5.1 Growing emphasis on payment integrity, dispute resolution, and regulatory compliance to fuel segmental growth 139

9.3.4 PAYMENT INTEGRITY 140
9.3.4.1 Increasing reliance on specialized service providers to reduce fraud to facilitate segmental growth 140
9.3.5 MEMBER & PROVIDER SUPPORT 141
9.3.5.1 Rising adoption of omnichannel customer engagement models to enhance member experience to expedite segmental growth 141
9.3.6 OTHER PAYER SERVICES 142
9.4 PROVIDER SERVICES 143
9.4.1 REVENUE CYCLE MANAGEMENT (RCM) 144
9.4.1.1 Front-end RCM 146
9.4.1.1.1 Rising enrollment in high-deductible health plans and evolving prior authorization requirements to drive market 146
9.4.1.2 Mid-cycle RCM 147
9.4.1.2.1 Increasing shortage of certified medical coders, documentation requirements, and heightened payer scrutiny to fuel segmental growth 147
9.4.1.3 Back-end RCM 147
9.4.1.3.1 Strong focus on improving claims resolution, reimbursement, and accounts receivable performance to spur demand 147
9.4.2 HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION 148
9.4.2.1 Clinical documentation improvement (CDI) 150
9.4.2.1.1 Rising regulatory scrutiny and emphasis on accurate diagnosis to contribute to segmental growth 150
9.4.2.2 Medical transcription & clinical documentation services 150
9.4.2.2.1 Increasing reliance on ambient AI, speech recognition, and automated technologies to augment segmental growth 150
9.4.2.3 Medical records management & release of information (ROI) 151
9.4.2.3.1 Evolving cybersecurity requirements and emphasis on secure health information exchange to drive market 151
9.4.3 PATIENT ENGAGEMENT & CONTACT CENTER SERVICES 152
9.4.3.1 Patient contact center & communication 153
9.4.3.1.1 Rising patient expectations, call volumes, and workforce shortages to bolster segmental growth 153
9.4.3.2 Patient financial counseling & assistance 154
9.4.3.2.1 Increasing enrollment in high-deductible health plans and out-of-pocket healthcare expenses to fuel segmental growth 154
9.4.3.3 Post-discharge follow-up & care navigation 155
9.4.3.3.1 Strong focus on improving care continuity, patient outcomes, and value-based healthcare delivery to expedite segmental growth 155
9.4.4 CLINICAL SUPPORT SERVICES 156
9.4.4.1 Teleradiology & remote diagnostic imaging 157
9.4.4.1.1 Rising need to improve diagnostic turnaround times and overcome persistent radiologist shortages to drive market 157

9.4.4.2 Remote patient monitoring (RPM) data management 158
9.4.4.2.1 Growing emphasis on reducing operational costs and improving care efficiency to accelerate segmental growth 158
9.4.4.3 Population health outreach & care coordination support 159
9.4.4.3.1 Increasing focus on direct patient care while supporting performance under value-based contracts to fuel segmental growth 159
9.4.5 NON-CLINICAL ADMINISTRATIVE SUPPORT SERVICES 160
9.4.5.1 Persistent workforce shortages and rising operational costs to augment segmental growth 160
9.4.6 OTHER PROVIDER SERVICES 160
10 HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL 162
10.1 INTRODUCTION 163
10.2 TRADITIONAL BPO 163
10.2.1 INCREASING COMPLEX, JUDGMENT-INTENSIVE PROCESSES TO BOLSTER SEGMENTAL GROWTH 163
10.3 AUTOMATION-ENABLED BPO 164
10.3.1 STRONG FOCUS ON IMPROVING PROCESSING SPEED, ENHANCING ACCURACY, AND LOWERING OPERATIONAL COSTS TO SPUR DEMAND 164
10.4 PLATFORM-BASED BPAAS 165
10.4.1 MOUNTING ADOPTION OF CLOUD-BASED, OUTCOME-DRIVEN TECHNOLOGIES TO FOSTER SEGMENTAL GROWTH 165
10.5 AI-ENABLED BPO 166
10.5.1 RAPID ADVANCES IN GEN AI, MACHINE LEARNING, NATURAL LANGUAGE PROCESSING, AND INTELLIGENT AUTOMATION TO EXPEDITE SEGMENTAL GROWTH 166
11 HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL 168
11.1 INTRODUCTION 169
11.2 ONSHORE 169
11.2.1 EVOLVING HEALTHCARE DATA PRIVACY REGULATIONS AND CYBERSECURITY REQUIREMENTS TO FOSTER SEGMENTAL GROWTH 169
11.3 OFFSHORE 170
11.3.1 ABILITY TO PROVIDE COST-EFFICIENT, SCALABLE SERVICES THROUGH SKILLED HEALTHCARE PROFESSIONALS TO BOOST SEGMENTAL GROWTH 170
11.4 HYBRID/MULTISHORE 171
11.4.1 FOCUS ON OPTIMIZING COST, QUALITY, REGULATORY COMPLIANCE, AND OPERATIONAL RESILIENCE TO AUGMENT SEGMENTAL GROWTH 171

12 HEALTHCARE BPO MARKET, BY REGION 173
12.1 INTRODUCTION 174
12.2 NORTH AMERICA 174
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 175
12.2.2 US 181
12.2.2.1 Rising administrative costs, complex regulatory environment, and demand for operational efficiency to fuel market growth 181
12.2.3 CANADA 187
12.2.3.1 Increasing healthcare digitalization and need for administrative efficiency to bolster market growth 187
12.3 EUROPE 193
12.3.1 GERMANY 199
12.3.1.1 Ongoing healthcare financing reforms and digital transformation to contribute to market growth 199
12.3.2 FRANCE 205
12.3.2.1 Increasing investment in digital health infrastructure to accelerate market growth 205
12.3.3 UK 211
12.3.3.1 Growing operational pressures and digital maturity requirements to foster market growth 211
12.3.4 ITALY 217
12.3.4.1 Rising healthcare digitization funding to modernize hospital IT infrastructure to drive market 217
12.3.5 SPAIN 223
12.3.5.1 Accelerating healthcare digitization and interoperability mandates to expedite market growth 223
12.3.6 REST OF EUROPE 229
12.4 ASIA PACIFIC 235
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 236
12.4.2 CHINA 242
12.4.2.1 Strong focus on developing smart hospitals to bolster market growth 242
12.4.3 JAPAN 248
12.4.3.1 Rapid standardization of electronic claims and medical-record exchange to support market growth 248
12.4.4 INDIA 254
12.4.4.1 Increasing digital health initiatives and standardized electronic claims infrastructure to create market growth opportunities 254
12.4.5 AUSTRALIA 260
12.4.5.1 Rising regulatory changes, healthcare digitization, and increasing administrative complexity to drive market 260
12.4.6 SOUTH KOREA 266
12.4.6.1 Mounting adoption of AI-based and digital health products to facilitate market growth 266
12.4.7 REST OF ASIA PACIFIC 272

12.5 LATIN AMERICA 278
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 278
12.5.2 BRAZIL 284
12.5.2.1 Evolving regulatory standards and private health insurance sector to foster market growth 284
12.5.3 MEXICO 290
12.5.3.1 Increasing rollout of digital health credentials to consolidate access to fragmented public health institutions to drive market 290
12.5.4 REST OF LATIN AMERICA 296
12.6 MIDDLE EAST & AFRICA 302
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 302
12.6.2 GCC COUNTRIES 308
12.6.2.1 Saudi Arabia 314
12.6.2.1.1 Rapid transformation of healthcare payment models to accelerate market growth 314
12.6.2.2 UAE 320
12.6.2.2.1 Rising claim values due to extension of mandatory health insurance to boost market growth 320
12.6.2.3 Rest of GCC 326
12.6.3 SOUTH AFRICA 332
12.6.3.1 Increasing investment in outsourced digital-engagement and claims-analytics to expedite market growth 332
12.6.4 REST OF MIDDLE EAST & AFRICA 338
13 COMPETITIVE LANDSCAPE 344
13.1 OVERVIEW 344
13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–2026 344
13.3 REVENUE ANALYSIS, 2021–2025 346
13.4 MARKET SHARE ANALYSIS, 2025 347
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 350
13.5.1 STARS 350
13.5.2 EMERGING LEADERS 350
13.5.3 PERVASIVE PLAYERS 350
13.5.4 PARTICIPANTS 351
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 352
13.5.5.1 Company footprint 352
13.5.5.2 Region footprint 353
13.5.5.3 Service footprint 354
13.5.5.4 Technology model footprint 355
13.5.5.5 Service delivery model footprint 356
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 357
13.6.1 PROGRESSIVE COMPANIES 357
13.6.2 RESPONSIVE COMPANIES 357
13.6.3 DYNAMIC COMPANIES 357
13.6.4 STARTING BLOCKS 357
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 359
13.6.5.1 Detailed list of key startups/SMEs 359
13.6.5.2 Competitive benchmarking of key startups/SMEs 359
13.7 COMPANY VALUATION AND FINANCIAL METRICS 360
13.8 BRAND/SOFTWARE COMPARISON 361
13.8.1 OPTUM, INC. (US) 361
13.8.2 ACCENTURE PLC (IRELAND) 361
13.8.3 COGNIZANT (US) 362
13.8.4 CAPGEMINI SE (FRANCE) 362
13.8.5 TATA CONSULTANCY SERVICES LIMITED (INDIA) 362
13.9 COMPETITIVE SCENARIO 362
13.9.1 PRODUCT/SERVICE LAUNCHES 362
13.9.2 DEALS 363
13.9.3 EXPANSIONS 364
14 COMPANY PROFILES 365
14.1 KEY PLAYERS 365
14.1.1 OPTUM, INC. 365
14.1.1.1 Business overview 365
14.1.1.2 Products/Services offered 366
14.1.1.3 Recent developments 367
14.1.1.3.1 Product/Service launches 367
14.1.1.3.2 Deals 367
14.1.1.4 MnM view 368
14.1.1.4.1 Key strengths/Right to win 368
14.1.1.4.2 Strategic choices 368
14.1.1.4.3 Weaknesses/Competitive threats 368
14.1.2 ACCENTURE PLC 369
14.1.2.1 Business overview 369
14.1.2.2 Products/Services offered 370
14.1.2.3 Recent developments 371
14.1.2.3.1 Deals 371
14.1.2.4 MnM view 373
14.1.2.4.1 Key strengths/Right to win 373
14.1.2.4.2 Strategic choices 373
14.1.2.4.3 Weaknesses/Competitive threats 373

14.1.3 TATA CONSULTANCY SERVICES LIMITED 374
14.1.3.1 Business overview 374
14.1.3.2 Products/Services offered 375
14.1.3.3 Recent developments 376
14.1.3.3.1 Product/Service launches 376
14.1.3.3.2 Deals 376
14.1.3.4 MnM view 377
14.1.3.4.1 Key strengths/Right to win 377
14.1.3.4.2 Strategic choices 377
14.1.3.4.3 Weaknesses/Competitive threats 377
14.1.4 COGNIZANT 378
14.1.4.1 Business overview 378
14.1.4.2 Products/Services offered 379
14.1.4.3 Recent developments 380
14.1.4.3.1 Product/Service launches 380
14.1.4.3.2 Deals 381
14.1.4.4 MnM view 382
14.1.4.4.1 Key strengths/Right to win 382
14.1.4.4.2 Strategic choices 382
14.1.4.4.3 Weaknesses/Competitive threats 382
14.1.5 CAPGEMINI SE 383
14.1.5.1 Business overview 383
14.1.5.2 Products/Services offered 384
14.1.5.3 Recent developments 385
14.1.5.3.1 Deals 385
14.1.5.3.2 Expansions 385
14.1.5.4 MnM view 386
14.1.5.4.1 Key strengths/Right to win 386
14.1.5.4.2 Strategic choices 386
14.1.5.4.3 Weaknesses/Competitive threats 386
14.1.6 INFOSYS LIMITED 387
14.1.6.1 Business overview 387
14.1.6.2 Products/Services offered 388
14.1.6.3 Recent developments 389
14.1.6.3.1 Deals 389
14.1.7 IQVIA HOLDINGS INC. 390
14.1.7.1 Business overview 390
14.1.7.2 Products/Services offered 391
14.1.7.3 Recent developments 392
14.1.7.3.1 Product/Service launches 392
14.1.7.3.2 Deals 392

14.1.8 WIPRO LIMITED 394
14.1.8.1 Business overview 394
14.1.8.2 Products/Services offered 395
14.1.8.3 Recent developments 396
14.1.8.3.1 Deals 396
14.1.9 NTT DATA GROUP CORPORATION 397
14.1.9.1 Business overview 397
14.1.9.2 Products/Services offered 398
14.1.9.3 Recent developments 398
14.1.9.3.1 Deals 398
14.1.9.3.2 Expansions 399
14.1.10 HCL TECHNOLOGIES LIMITED 400
14.1.10.1 Business overview 400
14.1.10.2 Products/Services offered 401
14.1.10.3 Recent developments 402
14.1.10.3.1 Deals 402
14.1.11 GENPACT LIMITED 403
14.1.11.1 Business overview 403
14.1.11.2 Products/Services offered 404
14.1.11.3 Recent developments 405
14.1.11.3.1 Product/Service launches 405
14.1.11.3.2 Deals 405
14.1.12 EXLSERVICE HOLDINGS, INC. 406
14.1.12.1 Business overview 406
14.1.12.2 Products/Services offered 407
14.1.12.3 Recent developments 408
14.1.12.3.1 Deals 408
14.1.13 SAGILITY LIMITED 409
14.1.13.1 Business overview 409
14.1.13.2 Products/Services offered 409
14.1.13.3 Recent developments 410
14.1.13.3.1 Deals 410
14.1.14 FIRSTSOURCE SOLUTIONS LIMITED 411
14.1.14.1 Business overview 411
14.1.14.2 Products/Services offered 412
14.1.14.3 Recent developments 413
14.1.14.3.1 Product/Service launches 413
14.1.14.3.2 Deals 413

14.1.15 CONDUENT INCORPORATED 414
14.1.15.1 Business overview 414
14.1.15.2 Products/Services offered 415
14.1.15.3 Recent developments 416
14.1.15.3.1 Deals 416
14.1.15.3.2 Other developments 416
14.1.16 COTIVITI, INC. 417
14.1.16.1 Business overview 417
14.1.16.2 Products/Services offered 417
14.1.16.3 Recent developments 418
14.1.16.3.1 Deals 418
14.1.16.3.2 Expansions 418
14.1.17 R1 RCM INC. 419
14.1.17.1 Business overview 419
14.1.17.2 Products/Services offered 419
14.1.17.3 Recent developments 420
14.1.17.3.1 Product/Service launches 420
14.1.17.3.2 Deals 420
14.1.17.3.3 Other developments 421
14.1.18 AGS HEALTH 422
14.1.18.1 Business overview 422
14.1.18.2 Products/Services offered 422
14.1.18.3 Recent developments 423
14.1.18.3.1 Product/Service launches 423
14.1.18.3.2 Deals 423
14.1.18.3.3 Expansions 423
14.1.19 OMEGA HEALTHCARE MANAGEMENT SERVICES 424
14.1.19.1 Business overview 424
14.1.19.2 Products/Services offered 424
14.1.19.3 Recent developments 425
14.1.19.3.1 Deals 425
14.1.20 GEBBS HEALTHCARE SOLUTIONS, INC. 426
14.1.20.1 Business overview 426
14.1.20.2 Products/Services offered 426
14.1.20.3 Recent developments 427
14.1.20.3.1 Deals 427
14.1.20.3.2 Other developments 427
14.2 OTHER PLAYERS 428
14.2.1 AKASA, INC. 428
14.2.2 CODAMETRIX, INC. 429
14.2.3 THOUGHTFUL AUTOMATION INC. 430
14.2.4 ADONIS TECHNOLOGY, INC. 431
14.2.5 RAPIDCLAIMS 432
15 RESEARCH METHODOLOGY 433
15.1 RESEARCH APPROACH 433
15.1.1 SECONDARY RESEARCH 434
15.1.1.1 List of key secondary sources 434
15.1.1.2 Key data from secondary sources 435
15.1.2 PRIMARY RESEARCH 435
15.1.2.1 List of primary interview participants 436
15.1.2.2 Key data from primary sources 437
15.1.2.3 Breakdown of primary interviews 437
15.1.2.4 Insights from primary experts 438
15.2 RESEARCH METHODOLOGY DESIGN 438
15.3 MARKET SIZE ESTIMATION 440
15.3.1 BOTTOM-UP APPROACH 440
15.3.2 TOP-DOWN APPROACH 440
15.4 DATA TRIANGULATION 444
15.5 RESEARCH ASSUMPTIONS 445
15.6 RESEARCH LIMITATIONS 445
15.7 RISK ANALYSIS 446
16 APPENDIX 447
16.1 DISCUSSION GUIDE 447
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 453
16.3 CUSTOMIZATION OPTIONS 455
16.4 RELATED REPORTS 455
16.5 AUTHOR DETAILS 456

LIST OF TABLES

TABLE 1 HEALTHCARE BPO MARKET: INCLUSIONS AND EXCLUSIONS 42
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 44
TABLE 3 HEALTHCARE BPO MARKET: IMPACT ANALYSIS 57
TABLE 4 HEALTHCARE DATA BREACHES IN US, 2025 65
TABLE 5 IMPACT OF PORTER’S FIVE FORCES 70
TABLE 6 ROLE OF COMPANIES IN HEALTHCARE BPO ECOSYSTEM 75
TABLE 7 INDICATIVE PRICE OF HEALTHCARE BPO SERVICES, BY SERVICE TYPE, 2025 (USD) 77
TABLE 8 INDICATIVE PRICE OF HEALTHCARE BPO SERVICES, BY REGION, 2025 (USD) 77
TABLE 9 LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 78
TABLE 10 CANON’S ACCOUNTS PAYABLE OUTSOURCING SOLUTIONS SUPPORT INVOICE PROCESSING OF BIOPHARMACEUTICAL COMPANY IN US 81
TABLE 11 C3I SOLUTIONS’ MEDICAL INFORMATION OUTSOURCING SERVICES OPTIMIZE BUSINESS COSTS AND EFFICIENCIES OF PHARMACEUTICAL COMPANY IN US 82
TABLE 12 FLATWORLD SOLUTIONS’ TRANSCRIPTION AUTOMATION OUTSOURCING SERVICES SUPPORT RADIOLOGISTS IN AUSTRALIA 83
TABLE 13 US-ADJUSTED RECIPROCAL TARIFF RATES 84
TABLE 14 LIST OF KEY PATENTS, 2015–2026 94
TABLE 15 AI-DRIVEN DENIAL ANALYTICS & CLAIMS ACCURACY 100
TABLE 16 AGENTIC AI FOR PRIOR AUTHORIZATION AUTOMATION 100
TABLE 17 AMBIENT AI FOR CLINICAL DOCUMENTATION & REVENUE CYCLE INTEGRITY 101
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107
TABLE 22 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107
TABLE 23 HEALTHCARE BPO REGULATIONS IN NORTH AMERICA 108
TABLE 24 HEALTHCARE BPO REGULATIONS IN EUROPE 109
TABLE 25 HEALTHCARE BPO REGULATIONS IN ASIA PACIFIC 109
TABLE 26 HEALTHCARE BPO REGULATIONS IN MIDDLE EAST & AFRICA 110
TABLE 27 HEALTHCARE BPO REGULATIONS IN LATIN AMERICA 110
TABLE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
TOP THREE END USERS (%) 112
TABLE 29 KEY BUYING CRITERIA FOR TOP THREE END USERS 113
TABLE 30 HEALTHCARE BPO MARKET: UNMET NEEDS 115
TABLE 31 HEALTHCARE BPO MARKET: END USERS’ EXPECTATIONS 116
TABLE 32 HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 119
TABLE 33 LIFE SCIENCES SERVICES: HEALTHCARE BPO MARKET, BY TYPE,
2024–2031 (USD MILLION) 120
TABLE 34 LIFE SCIENCES SERVICES: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 120
TABLE 35 RESEARCH & CLINICAL DEVELOPMENT: HEALTHCARE BPO MARKET,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 121
TABLE 36 RESEARCH & CLINICAL DEVELOPMENT: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 122
TABLE 37 DISCOVERY & PRECLINICAL: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 123
TABLE 38 CLINICAL TRIAL MANAGEMENT: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 124
TABLE 39 CLINICAL DATA & BIOSTATISTICS: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 125
TABLE 40 RWE & LATE-PHASE: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 126
TABLE 41 OTHER R&D SERVICES: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 127
TABLE 42 MANUFACTURING & PACKAGING: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 128
TABLE 43 SUPPLY CHAIN & LOGISTICS: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 129
TABLE 44 COMMERCIALIZATION & MEDICAL AFFAIRS: HEALTHCARE BPO MARKET,
BY REGION, 2024–2031 (USD MILLION) 130
TABLE 45 SAFETY, REGULATORY & QUALITY: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 131
TABLE 46 OTHER LIFE SCIENCES SERVICES: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 131
TABLE 47 PAYER SERVICES: HEALTHCARE BPO MARKET, BY TYPE,
2024–2031 (USD MILLION) 132
TABLE 48 PAYER SERVICES: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 133
TABLE 49 MEMBER ENROLLMENT & BILLING: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 134
TABLE 50 PROVIDER NETWORK MANAGEMENT: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 51 CLAIMS ADMINISTRATION: HEALTHCARE BPO MARKET, BY SERVICE TYPE,
2024–2031 (USD MILLION) 136
TABLE 52 CLAIMS ADMINISTRATION: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 136
TABLE 53 CLAIMS INTAKE & DATA CAPTURE: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 137
TABLE 54 CLAIMS ADJUDICATION & SETTLEMENT: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 138
TABLE 55 CLAIMS EDITING, PRICING & REPRICING: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 138
TABLE 56 CLAIMS ADJUSTMENT, DENIALS & REWORK: HEALTHCARE BPO MARKET,
BY REGION, 2024–2031 (USD MILLION) 139
TABLE 57 CLAIMS PAYMENT & REMITTANCE SUPPORT: HEALTHCARE BPO MARKET,
BY REGION, 2024–2031 (USD MILLION) 140
TABLE 58 PAYMENT INTEGRITY: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 141
TABLE 59 MEMBER & PROVIDER SUPPORT: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 142
TABLE 60 OTHER PAYER SERVICES: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 143
TABLE 61 PROVIDER SERVICES: HEALTHCARE BPO MARKET, BY TYPE,
2024–2031 (USD MILLION) 144
TABLE 62 PROVIDER SERVICES: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 144
TABLE 63 REVENUE CYCLE MANAGEMENT (RCM): HEALTHCARE BPO MARKET,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 145
TABLE 64 REVENUE CYCLE MANAGEMENT (RCM): HEALTHCARE BPO MARKET,
BY REGION, 2024–2031 (USD MILLION) 145
TABLE 65 FRONT-END RCM: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 146
TABLE 66 MID-CYCLE RCM: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 147
TABLE 67 BACK-END RCM: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 148
TABLE 68 HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION: HEALTHCARE BPO MARKET, BY SERVICE TYPE, 2024–2031 (USD MILLION) 149
TABLE 69 HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 149
TABLE 70 CLINICAL DOCUMENTATION IMPROVEMENT (CDI): HEALTHCARE BPO MARKET,
BY REGION, 2024–2031 (USD MILLION) 150
TABLE 71 MEDICAL TRANSCRIPTION & CLINICAL DOCUMENTATION SERVICES: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 151
TABLE 72 MEDICAL RECORDS MANAGEMENT & RELEASE OF INFORMATION (ROI): HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 152
TABLE 73 PATIENT ENGAGEMENT & CONTACT CENTER SERVICES: HEALTHCARE BPO MARKET, BY TYPE, 2024–2031 (USD MILLION) 153
TABLE 74 PATIENT ENGAGEMENT & CONTACT CENTER SERVICES: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 153
TABLE 75 PATIENT CONTACT CENTER & COMMUNICATION: HEALTHCARE BPO MARKET,
BY REGION, 2024–2031 (USD MILLION) 154
TABLE 76 PATIENT FINANCIAL COUNSELING & ASSISTANCE: HEALTHCARE BPO MARKET,
BY REGION, 2024–2031 (USD MILLION) 155
TABLE 77 POST-DISCHARGE FOLLOW-UP & CARE NAVIGATION: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 156
TABLE 78 CLINICAL SUPPORT SERVICES: HEALTHCARE BPO MARKET, BY TYPE,
2024–2031 (USD MILLION) 156
TABLE 79 CLINICAL SUPPORT SERVICES: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 157
TABLE 80 TELERADIOLOGY & REMOTE DIAGNOSTIC IMAGING: HEALTHCARE BPO MARKET,
BY REGION, 2024–2031 (USD MILLION) 158
TABLE 81 REMOTE PATIENT MONITORING (RPM) DATA MANAGEMENT: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 159
TABLE 82 POPULATION HEALTH OUTREACH & CARE COORDINATION SUPPORT: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 159
TABLE 83 NON-CLINICAL ADMINISTRATIVE SUPPORT SERVICES: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 160
TABLE 84 OTHER PROVIDER SERVICES: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 161
TABLE 85 HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL, 2024–2031 (USD MILLION) 163
TABLE 86 TRADITIONAL BPO: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 164
TABLE 87 AUTOMATION-ENABLED BPO: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 165
TABLE 88 PLATFORM-BASED BPAAS: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 166
TABLE 89 AI-ENABLED BPO: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 167
TABLE 90 HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 169
TABLE 91 ONSHORE: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 170
TABLE 92 OFFSHORE: HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 171
TABLE 93 HYBRID/MULTISHORE: HEALTHCARE BPO MARKET, BY REGION,
2024–2031 (USD MILLION) 172
TABLE 94 HEALTHCARE BPO MARKET, BY REGION, 2024–2031 (USD MILLION) 174
TABLE 95 NORTH AMERICA: HEALTHCARE BPO MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 176
TABLE 96 NORTH AMERICA: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 176
TABLE 97 NORTH AMERICA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 176
TABLE 98 NORTH AMERICA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 177
TABLE 99 NORTH AMERICA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 177
TABLE 100 NORTH AMERICA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 178
TABLE 101 NORTH AMERICA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE 2024–2031 (USD MILLION) 178
TABLE 102 NORTH AMERICA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 179
TABLE 103 NORTH AMERICA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 179
TABLE 104 NORTH AMERICA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 180
TABLE 105 NORTH AMERICA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 180
TABLE 106 NORTH AMERICA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 180
TABLE 107 NORTH AMERICA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL, 2024–2031 (USD MILLION) 181
TABLE 108 US: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 182
TABLE 109 US: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE,
2024–2031 (USD MILLION) 182
TABLE 110 US: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 182
TABLE 111 US: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 183
TABLE 112 US: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 183
TABLE 113 US: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 184
TABLE 114 US: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM),
BY SERVICE TYPE, 2024–2031 (USD MILLION) 184
TABLE 115 US: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 185
TABLE 116 US: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 185
TABLE 117 US: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 186
TABLE 118 US: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 186
TABLE 119 US: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 186
TABLE 120 CANADA: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 187
TABLE 121 CANADA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 188
TABLE 122 CANADA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 188
TABLE 123 CANADA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 189
TABLE 124 CANADA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 189
TABLE 125 CANADA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE
2024–2031 (USD MILLION) 190
TABLE 126 CANADA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 190
TABLE 127 CANADA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 191
TABLE 128 CANADA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 191
TABLE 129 CANADA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 130 CANADA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 192
TABLE 131 CANADA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 192
TABLE 132 EUROPE: HEALTHCARE BPO MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 193
TABLE 133 EUROPE: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 194
TABLE 134 EUROPE: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 194
TABLE 135 EUROPE: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 194
TABLE 136 EUROPE: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 195
TABLE 137 EUROPE: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 195
TABLE 138 EUROPE: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 196
TABLE 139 EUROPE: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 196
TABLE 140 EUROPE: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 197
TABLE 141 EUROPE: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 142 EUROPE: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 198
TABLE 143 EUROPE: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 198
TABLE 144 EUROPE: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 198
TABLE 145 GERMANY: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 199
TABLE 146 GERMANY: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 200
TABLE 147 GERMANY: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 200
TABLE 148 GERMANY: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 149 GERMANY: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 201
TABLE 150 GERMANY: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 202
TABLE 151 GERMANY: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 202
TABLE 152 GERMANY: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 203
TABLE 153 GERMANY: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 154 GERMANY: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 155 GERMANY: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 204
TABLE 156 GERMANY: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 204
TABLE 157 FRANCE: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 205
TABLE 158 FRANCE: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 206
TABLE 159 FRANCE: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 206
TABLE 160 FRANCE: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 207
TABLE 161 FRANCE: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 207
TABLE 162 FRANCE: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 208
TABLE 163 FRANCE: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 208
TABLE 164 FRANCE: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 209
TABLE 165 FRANCE: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 166 FRANCE: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 210
TABLE 167 FRANCE: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 210
TABLE 168 FRANCE: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 210
TABLE 169 UK: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 211
TABLE 170 UK: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE,
2024–2031 (USD MILLION) 212
TABLE 171 UK: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 212
TABLE 172 UK: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 213
TABLE 173 UK: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 213
TABLE 174 UK: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 214
TABLE 175 UK: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM),
BY SERVICE TYPE, 2024–2031 (USD MILLION) 214
TABLE 176 UK: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 215
TABLE 177 UK: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 215
TABLE 178 UK: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 179 UK: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 216
TABLE 180 UK: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 216
TABLE 181 ITALY: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 217
TABLE 182 ITALY: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE,
2024–2031 (USD MILLION) 218
TABLE 183 ITALY: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 218
TABLE 184 ITALY: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 185 ITALY: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 219
TABLE 186 ITALY: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 187 ITALY: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM),
BY SERVICE TYPE, 2024–2031 (USD MILLION) 220
TABLE 188 ITALY: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 221
TABLE 189 ITALY: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 221
TABLE 190 ITALY: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 191 ITALY: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 222
TABLE 192 ITALY: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 222
TABLE 193 SPAIN: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 223
TABLE 194 SPAIN: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 195 SPAIN: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 224
TABLE 196 SPAIN: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 225
TABLE 197 SPAIN: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 225
TABLE 198 SPAIN: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE
2024–2031 (USD MILLION) 226
TABLE 199 SPAIN: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM),
BY SERVICE TYPE, 2024–2031 (USD MILLION) 226
TABLE 200 SPAIN: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 227
TABLE 201 SPAIN: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 202 SPAIN: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 203 SPAIN: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 228
TABLE 204 SPAIN: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 228
TABLE 205 REST OF EUROPE: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 229
TABLE 206 REST OF EUROPE: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 230
TABLE 207 REST OF EUROPE: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 230
TABLE 208 REST OF EUROPE: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 209 REST OF EUROPE: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 231
TABLE 210 REST OF EUROPE: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 211 REST OF EUROPE: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 232
TABLE 212 REST OF EUROPE: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 233
TABLE 213 REST OF EUROPE: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 233
TABLE 214 REST OF EUROPE: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 215 REST OF EUROPE: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 234
TABLE 216 REST OF EUROPE: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL, 2024–2031 (USD MILLION) 234
TABLE 217 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 237
TABLE 218 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 237
TABLE 219 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 237
TABLE 220 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 238
TABLE 221 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 238
TABLE 222 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 239
TABLE 223 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 239
TABLE 224 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 240
TABLE 225 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 240
TABLE 226 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 227 ASIA PACIFIC: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 228 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 242
TABLE 229 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 242
TABLE 230 CHINA: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 243
TABLE 231 CHINA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 243
TABLE 232 CHINA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 244
TABLE 233 CHINA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 244
TABLE 234 CHINA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 245
TABLE 235 CHINA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 236 CHINA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM),
BY SERVICE TYPE, 2024–2031 (USD MILLION) 246
TABLE 237 CHINA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 246
TABLE 238 CHINA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 239 CHINA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 240 CHINA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 247
TABLE 241 CHINA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 248
TABLE 242 JAPAN: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 249
TABLE 243 JAPAN: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 244 JAPAN: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 249
TABLE 245 JAPAN: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 246 JAPAN: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 250
TABLE 247 JAPAN: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 251
TABLE 248 JAPAN: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM),
BY SERVICE TYPE, 2024–2031 (USD MILLION) 251
TABLE 249 JAPAN: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 252
TABLE 250 JAPAN: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 251 JAPAN: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 252 JAPAN: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 253
TABLE 253 JAPAN: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 253
TABLE 254 INDIA: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 254
TABLE 255 INDIA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 256 INDIA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 255
TABLE 257 INDIA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 256
TABLE 258 INDIA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 256
TABLE 259 INDIA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 260 INDIA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM),
BY SERVICE TYPE, 2024–2031 (USD MILLION) 257
TABLE 261 INDIA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 258
TABLE 262 INDIA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 263 INDIA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 264 INDIA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 259
TABLE 265 INDIA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 259
TABLE 266 AUSTRALIA: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 260
TABLE 267 AUSTRALIA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 261
TABLE 268 AUSTRALIA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 261
TABLE 269 AUSTRALIA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 270 AUSTRALIA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 262
TABLE 271 AUSTRALIA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 272 AUSTRALIA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 263
TABLE 273 AUSTRALIA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 264
TABLE 274 AUSTRALIA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 275 AUSTRALIA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 265
TABLE 276 AUSTRALIA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 265
TABLE 277 AUSTRALIA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 265
TABLE 278 SOUTH KOREA: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 266
TABLE 279 SOUTH KOREA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 280 SOUTH KOREA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 267
TABLE 281 SOUTH KOREA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 268
TABLE 282 SOUTH KOREA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 268
TABLE 283 SOUTH KOREA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 269
TABLE 284 SOUTH KOREA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 269
TABLE 285 SOUTH KOREA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 270
TABLE 286 SOUTH KOREA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 287 SOUTH KOREA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 288 SOUTH KOREA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 271
TABLE 289 SOUTH KOREA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 271
TABLE 290 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 272
TABLE 291 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 292 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 273
TABLE 293 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 294 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 274
TABLE 295 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 296 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 275
TABLE 297 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 276
TABLE 298 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 299 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 300 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL, 2024–2031 (USD MILLION) 277
TABLE 301 REST OF ASIA PACIFIC: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL, 2024–2031 (USD MILLION) 277
TABLE 302 LATIN AMERICA: HEALTHCARE BPO MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 279
TABLE 303 LATIN AMERICA: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 279
TABLE 304 LATIN AMERICA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 305 LATIN AMERICA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 280
TABLE 306 LATIN AMERICA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 280
TABLE 307 LATIN AMERICA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 281
TABLE 308 LATIN AMERICA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 309 LATIN AMERICA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 282
TABLE 310 LATIN AMERICA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 282
TABLE 311 LATIN AMERICA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 312 LATIN AMERICA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 313 LATIN AMERICA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 283
TABLE 314 LATIN AMERICA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL, 2024–2031 (USD MILLION) 284
TABLE 315 BRAZIL: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 285
TABLE 316 BRAZIL: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 285
TABLE 317 BRAZIL: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 285
TABLE 318 BRAZIL: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 286
TABLE 319 BRAZIL: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 286
TABLE 320 BRAZIL: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 287
TABLE 321 BRAZIL: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 287
TABLE 322 BRAZIL: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 288
TABLE 323 BRAZIL: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 324 BRAZIL: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 325 BRAZIL: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 289
TABLE 326 BRAZIL: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 289
TABLE 327 MEXICO: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 290
TABLE 328 MEXICO: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 329 MEXICO: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 291
TABLE 330 MEXICO: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 292
TABLE 331 MEXICO: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 292
TABLE 332 MEXICO: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 333 MEXICO: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 293
TABLE 334 MEXICO: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 294
TABLE 335 MEXICO: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 294
TABLE 336 MEXICO: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 295
TABLE 337 MEXICO: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 295
TABLE 338 MEXICO: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 295
TABLE 339 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 296
TABLE 340 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 297
TABLE 341 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 297
TABLE 342 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR PAYER SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 298
TABLE 343 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 298
TABLE 344 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 299
TABLE 345 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 299
TABLE 346 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 300
TABLE 347 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 348 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 301
TABLE 349 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL, 2024–2031 (USD MILLION) 301
TABLE 350 REST OF LATIN AMERICA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL, 2024–2031 (USD MILLION) 301
TABLE 351 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 303
TABLE 352 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 303
TABLE 353 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 354 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 304
TABLE 355 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR PAYER SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 304
TABLE 356 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 305
TABLE 357 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 305
TABLE 358 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 306
TABLE 359 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 306
TABLE 360 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 361 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 362 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL, 2024–2031 (USD MILLION) 307
TABLE 363 MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET,
BY SERVICE DELIVERY MODEL, 2024–2031 (USD MILLION) 308
TABLE 364 GCC: HEALTHCARE BPO MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 308
TABLE 365 GCC: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 309
TABLE 366 GCC: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE,
2024–2031 (USD MILLION) 309
TABLE 367 GCC: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 309
TABLE 368 GCC: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 310
TABLE 369 GCC: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 310
TABLE 370 GCC: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 311
TABLE 371 GCC: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM),
BY SERVICE TYPE, 2024–2031 (USD MILLION) 311
TABLE 372 GCC: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 312
TABLE 373 GCC: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 312
TABLE 374 GCC: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 313
TABLE 375 GCC: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 313
TABLE 376 GCC: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 313
TABLE 377 SAUDI ARABIA: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 314
TABLE 378 SAUDI ARABIA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 315
TABLE 379 SAUDI ARABIA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 315
TABLE 380 SAUDI ARABIA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 316
TABLE 381 SAUDI ARABIA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 316
TABLE 382 SAUDI ARABIA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 383 SAUDI ARABIA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 317
TABLE 384 SAUDI ARABIA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 318
TABLE 385 SAUDI ARABIA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 386 SAUDI ARABIA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 387 SAUDI ARABIA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 319
TABLE 388 SAUDI ARABIA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 319
TABLE 389 UAE: HEALTHCARE BPO MARKET, BY SERVICE, 2024–2031 (USD MILLION) 320
TABLE 390 UAE: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE,
2024–2031 (USD MILLION) 321
TABLE 391 UAE: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 321
TABLE 392 UAE: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 322
TABLE 393 UAE: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 322
TABLE 394 UAE: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 323
TABLE 395 UAE: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM),
BY SERVICE TYPE, 2024–2031 (USD MILLION) 323
TABLE 396 UAE: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 324
TABLE 397 UAE: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 324
TABLE 398 UAE: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 399 UAE: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 325
TABLE 400 UAE: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 325
TABLE 401 REST OF GCC: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 326
TABLE 402 REST OF GCC: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 327
TABLE 403 REST OF GCC: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 327
TABLE 404 REST OF GCC: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 328
TABLE 405 REST OF GCC: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 328
TABLE 406 REST OF GCC: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 407 REST OF GCC: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 329
TABLE 408 REST OF GCC: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 330
TABLE 409 REST OF GCC: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 330
TABLE 410 REST OF GCC: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 411 REST OF GCC: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 331
TABLE 412 REST OF GCC: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 331
TABLE 413 SOUTH AFRICA: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 332
TABLE 414 SOUTH AFRICA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 333
TABLE 415 SOUTH AFRICA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 333
TABLE 416 SOUTH AFRICA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 334
TABLE 417 SOUTH AFRICA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 334
TABLE 418 SOUTH AFRICA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 335
TABLE 419 SOUTH AFRICA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 335
TABLE 420 SOUTH AFRICA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION, BY SERVICE TYPE,
2024–2031 (USD MILLION) 336
TABLE 421 SOUTH AFRICA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 422 SOUTH AFRICA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES,
BY TYPE, 2024–2031 (USD MILLION) 337
TABLE 423 SOUTH AFRICA: HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL,
2024–2031 (USD MILLION) 337
TABLE 424 SOUTH AFRICA: HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL,
2024–2031 (USD MILLION) 337
TABLE 425 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET, BY SERVICE,
2024–2031 (USD MILLION) 338
TABLE 426 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR LIFE SCIENCES SERVICES, BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 427 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR RESEARCH & CLINICAL DEVELOPMENT, BY SERVICE TYPE, 2024–2031 (USD MILLION) 339
TABLE 428 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR PAYER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 340
TABLE 429 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR CLAIMS ADMINISTRATION, BY SERVICE TYPE, 2024–2031 (USD MILLION) 340
TABLE 430 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR PROVIDER SERVICES, BY TYPE, 2024–2031 (USD MILLION) 341
TABLE 431 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR REVENUE CYCLE MANAGEMENT (RCM), BY SERVICE TYPE, 2024–2031 (USD MILLION) 341
TABLE 432 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION,
BY SERVICE TYPE, 2024–2031 (USD MILLION) 342
TABLE 433 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR PATIENT ENGAGEMENT & CONTACT CENTER SERVICES, BY TYPE,
2024–2031 (USD MILLION) 342
TABLE 434 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET FOR CLINICAL SUPPORT SERVICES, BY TYPE, 2024–2031 (USD MILLION) 343
TABLE 435 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET,
BY TECHNOLOGY MODEL, 2024–2031 (USD MILLION) 343
TABLE 436 REST OF MIDDLE EAST & AFRICA: HEALTHCARE BPO MARKET,
BY SERVICE DELIVERY MODEL, 2024–2031 (USD MILLION) 343
TABLE 437 HEALTHCARE BPO MARKET: OVERVIEW OF STRATEGIES ADOPTED
BY KEY PLAYERS, JANUARY 2023–JULY 2026 345
TABLE 438 HEALTHCARE BPO MARKET: DEGREE OF COMPETITION, 2025 349
TABLE 439 HEALTHCARE BPO MARKET: REGION FOOTPRINT 353
TABLE 440 HEALTHCARE BPO MARKET: SERVICE FOOTPRINT 354
TABLE 441 HEALTHCARE BPO MARKET: TECHNOLOGY MODEL FOOTPRINT 355
TABLE 442 HEALTHCARE BPO MARKET: SERVICE DELIVERY MODEL FOOTPRINT 356
TABLE 443 HEALTHCARE BPO MARKET: DETAILED LIST OF KEY STARTUPS/SMES 359
TABLE 444 HEALTHCARE BPO MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 359
TABLE 445 HEALTHCARE BPO MARKET: PRODUCT/SERVICE LAUNCHES,
JANUARY 2023–JULY 2026 362
TABLE 446 HEALTHCARE BPO MARKET: DEALS, JANUARY 2023–JULY 2026 363
TABLE 447 HEALTHCARE BPO MARKET: EXPANSIONS, JANUARY 2023–JULY 2026 364
TABLE 448 OPTUM, INC.: COMPANY OVERVIEW 365
TABLE 449 OPTUM, INC.: PRODUCTS/SERVICES OFFERED 366
TABLE 450 OPTUM, INC.: PRODUCT/SERVICE LAUNCHES 367
TABLE 451 OPTUM, INC.: DEALS 367
TABLE 452 ACCENTURE PLC: COMPANY OVERVIEW 369
TABLE 453 ACCENTURE PLC: PRODUCTS/SERVICES OFFERED 370
TABLE 454 ACCENTURE PLC: DEALS 371
TABLE 455 TATA CONSULTANCY SERVICES LIMITED: COMPANY OVERVIEW 374
TABLE 456 TATA CONSULTANCY SERVICES LIMITED: PRODUCTS/SERVICES OFFERED 375
TABLE 457 TATA CONSULTANCY SERVICES LIMITED: PRODUCT/SERVICE LAUNCHES 376
TABLE 458 TATA CONSULTANCY SERVICES LIMITED: DEALS 376
TABLE 459 COGNIZANT: COMPANY OVERVIEW 378
TABLE 460 COGNIZANT: PRODUCTS/SERVICES OFFERED 379
TABLE 461 COGNIZANT: PRODUCT/SERVICE LAUNCHES 380
TABLE 462 COGNIZANT: DEALS 381
TABLE 463 CAPGEMINI SE: COMPANY OVERVIEW 383
TABLE 464 CAPGEMINI SE: PRODUCTS/SERVICES OFFERED 384
TABLE 465 CAPGEMINI SE: DEALS 385
TABLE 466 CAPGEMINI SE: EXPANSIONS 385
TABLE 467 INFOSYS LIMITED: COMPANY OVERVIEW 387
TABLE 468 INFOSYS LIMITED: PRODUCTS/SERVICES OFFERED 388
TABLE 469 INFOSYS LIMITED: DEALS 389
TABLE 470 IQVIA HOLDINGS INC.: COMPANY OVERVIEW 390
TABLE 471 IQVIA HOLDINGS INC.: PRODUCTS/SERVICES OFFERED 391
TABLE 472 IQVIA HOLDINGS INC.: PRODUCT/SERVICE LAUNCHES 392
TABLE 473 IQVIA HOLDINGS INC.: DEALS 392
TABLE 474 WIPRO LIMITED: COMPANY OVERVIEW 394
TABLE 475 WIPRO LIMITED: PRODUCTS/SERVICES OFFERED 395
TABLE 476 WIPRO LIMITED: DEALS 396
TABLE 477 NTT DATA GROUP CORPORATION: COMPANY OVERVIEW 397
TABLE 478 NTT DATA GROUP CORPORATION: PRODUCTS/SERVICES OFFERED 398
TABLE 479 NTT DATA GROUP CORPORATION: DEALS 398
TABLE 480 NTT DATA GROUP CORPORATION: EXPANSIONS 399
TABLE 481 HCL TECHNOLOGIES LIMITED: COMPANY OVERVIEW 400
TABLE 482 HCL TECHNOLOGIES LIMITED: PRODUCTS/SERVICES OFFERED 401
TABLE 483 HCL TECHNOLOGIES LIMITED: DEALS 402
TABLE 484 GENPACT LIMITED: COMPANY OVERVIEW 403
TABLE 485 GENPACT LIMITED: PRODUCTS/SERVICES OFFERED 404
TABLE 486 GENPACT LIMITED: PRODUCT/SERVICE LAUNCHES 405
TABLE 487 GENPACT LIMITED: DEALS 405
TABLE 488 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW 406
TABLE 489 EXLSERVICE HOLDINGS, INC.: PRODUCTS/SERVICES OFFERED 407
TABLE 490 EXLSERVICE HOLDINGS, INC.: DEALS 408
TABLE 491 SAGILITY LIMITED: COMPANY OVERVIEW 409
TABLE 492 SAGILITY LIMITED: PRODUCTS/SERVICES OFFERED 409
TABLE 493 SAGILITY LIMITED: DEALS 410
TABLE 494 FIRSTSOURCE SOLUTIONS LIMITED: COMPANY OVERVIEW 411
TABLE 495 FIRSTSOURCE SOLUTIONS LIMITED: PRODUCTS/SERVICES OFFERED 412
TABLE 496 FIRSTSOURCE SOLUTIONS LIMITED: PRODUCT/SERVICE LAUNCHES 413
TABLE 497 FIRSTSOURCE SOLUTIONS LIMITED: DEALS 413
TABLE 498 CONDUENT INCORPORATED: COMPANY OVERVIEW 414
TABLE 499 CONDUENT INCORPORATED: PRODUCTS/SERVICES OFFERED 415
TABLE 500 CONDUENT INCORPORATED: DEALS 416
TABLE 501 CONDUENT INCORPORATED: OTHER DEVELOPMENTS 416
TABLE 502 COTIVITI, INC.: COMPANY OVERVIEW 417
TABLE 503 COTIVITI, INC.: PRODUCTS/SERVICES OFFERED 417
TABLE 504 COTIVITI, INC.: DEALS 418
TABLE 505 COTIVITI, INC.: EXPANSIONS 418
TABLE 506 R1 RCM INC.: COMPANY OVERVIEW 419
TABLE 507 R1 RCM INC.: PRODUCTS/SERVICES OFFERED 419
TABLE 508 R1 RCM INC.: PRODUCT/SERVICE LAUNCHES 420
TABLE 509 R1 RCM INC.: DEALS 420
TABLE 510 R1 RCM INC.: OTHER DEVELOPMENTS 421
TABLE 511 AGS HEALTH: COMPANY OVERVIEW 422
TABLE 512 AGS HEALTH: PRODUCTS/SERVICES OFFERED 422
TABLE 513 AGS HEALTH: PRODUCT/SERVICE LAUNCHES 423
TABLE 514 AGS HEALTH: DEALS 423
TABLE 515 AGS HEALTH: EXPANSIONS 423
TABLE 516 OMEGA HEALTHCARE MANAGEMENT SERVICES: COMPANY OVERVIEW 424
TABLE 517 OMEGA HEALTHCARE MANAGEMENT SERVICES: PRODUCTS/SERVICES OFFERED 424
TABLE 518 OMEGA HEALTHCARE MANAGEMENT SERVICES: DEALS 425
TABLE 519 GEBBS HEALTHCARE SOLUTIONS, INC.: COMPANY OVERVIEW 426
TABLE 520 GEBBS HEALTHCARE SOLUTIONS, INC.: PRODUCTS/SERVICES OFFERED 426
TABLE 521 GEBBS HEALTHCARE SOLUTIONS, INC.: DEALS 427
TABLE 522 GEBBS HEALTHCARE SOLUTIONS, INC.: OTHER DEVELOPMENTS 427
TABLE 523 AKASA, INC. COMPANY OVERVIEW 428
TABLE 524 CODAMETRIX, INC. COMPANY OVERVIEW 429
TABLE 525 THOUGHTFUL AUTOMATION INC.: COMPANY OVERVIEW 430
TABLE 526 ADONIS TECHNOLOGY, INC.: COMPANY OVERVIEW 431
TABLE 527 RAPIDCLAIMS: COMPANY OVERVIEW 432
TABLE 528 HEALTHCARE BPO MARKET: RESEARCH ASSUMPTIONS 445
TABLE 529 HEALTHCARE BPO MARKET: RISK ANALYSIS 446

LIST OF FIGURES

FIGURE 1 HEALTHCARE BPO MARKET SEGMENTATION 41
FIGURE 2 HEALTHCARE BPO MARKET REGIONAL SCOPE 42
FIGURE 3 HEALTHCARE BPO MARKET: DURATION CONSIDERED 44
FIGURE 4 HEALTHCARE BPO MARKET SCENARIO 48
FIGURE 5 GLOBAL HEALTHCARE BPO MARKET SIZE, 2024–2031 48
FIGURE 6 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE BPO MARKET, 2023–2026 49
FIGURE 7 DISRUPTIONS INFLUENCING GROWTH OF HEALTHCARE BPO MARKET 50
FIGURE 8 HIGH-GROWTH SEGMENTS IN HEALTHCARE BPO MARKET, 2026–2031 51
FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HEALTHCARE BPO MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 52
FIGURE 10 RAPID HEALTHCARE DIGITALIZATION AND EXPANDING HEALTH INSURANCE COVERAGE TO BOLSTER HEALTHCARE BPO MARKET GROWTH 53
FIGURE 11 LIFE SCIENCES SERVICES SEGMENT AND US HELD LARGEST SHARE OF HEALTHCARE BPO MARKER IN NORTH AMERICA IN 2025 54
FIGURE 12 AI-ENABLED BPO SEGMENT TO EXHIBIT HIGHEST CAGR FROM 2026 TO 2031 54
FIGURE 13 OFFSHORE SEGMENT TO HOLD LARGEST SHARE OF HEALTHCARE BPO MARKET
IN 2026 AND 2031 55
FIGURE 14 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 55
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
FIGURE 16 PORTER’S FIVE FORCES ANALYSIS 69
FIGURE 17 HEALTHCARE BPO SUPPLY CHAIN 74
FIGURE 18 HEALTHCARE BPO ECOSYSTEM 75
FIGURE 19 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 80
FIGURE 20 INVESTMENT AND FUNDING SCENARIO, BY COMPANY, 2025 80
FIGURE 21 GLOBAL PATENT PUBLICATION TRENDS IN HEALTHCARE BPO MARKET,
2015–2026 93
FIGURE 22 PATENTS APPLIED AND GRANTED, JANUARY 2015–JULY 2026 93
FIGURE 23 TOP APPLICANTS FOR HEALTHCARE BPO PATENTS,
JANUARY 2015–JULY 2026 (COUNTRY/REGION) 94
FIGURE 24 MARKET POTENTIAL OF AI/GEN AI ACROSS INDUSTRIES 98
FIGURE 25 IMPACT OF AI/GEN AI ON INTERCONNECTED ECOSYSTEMS 101
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 112
FIGURE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS 113
FIGURE 28 NORTH AMERICA: HEALTHCARE BPO MARKET SNAPSHOT 175
FIGURE 29 ASIA PACIFIC: HEALTHCARE BPO MARKET SNAPSHOT 236
FIGURE 30 HEALTHCARE BPO MARKET: REVENUE ANALYSIS OF TOP FOUR PLAYERS,
2021–2025 347
FIGURE 31 MARKET SHARE ANALYSIS OF COMPANIES OFFERING HEALTHCARE BPO SERVICES/SOLUTIONS, 2025 348
FIGURE 32 HEALTHCARE BPO MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 351
FIGURE 33 HEALTHCARE BPO MARKET: COMPANY FOOTPRINT 352
FIGURE 34 HEALTHCARE BPO MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 358
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF HEALTHCARE BPO VENDORS 360
FIGURE 36 FINANCIAL METRICS (EV/EBITDA) 360
FIGURE 37 BRAND/PRODUCT COMPARATIVE ANALYSIS 361
FIGURE 38 OPTUM, INC.: COMPANY SNAPSHOT (2025) 366
FIGURE 39 ACCENTURE PLC: COMPANY SNAPSHOT (2025) 370
FIGURE 40 TATA CONSULTANCY SERVICES LIMITED: COMPANY SNAPSHOT (2025) 375
FIGURE 41 COGNIZANT: COMPANY SNAPSHOT (2025) 379
FIGURE 42 CAPGEMINI SE: COMPANY SNAPSHOT (2025) 384
FIGURE 43 INFOSYS LIMITED: COMPANY SNAPSHOT (2025) 388
FIGURE 44 IQVIA HOLDINGS INC.: COMPANY SNAPSHOT (2025) 391
FIGURE 45 WIPRO LIMITED: COMPANY SNAPSHOT (2025) 395
FIGURE 46 NTT DATA GROUP CORPORATION: COMPANY SNAPSHOT (2025) 397
FIGURE 47 HCL TECHNOLOGIES LIMITED: COMPANY SNAPSHOT (2025) 401
FIGURE 48 GENPACT LIMITED: COMPANY SNAPSHOT (2025) 404
FIGURE 49 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2025) 407
FIGURE 50 FIRSTSOURCE SOLUTIONS LIMITED: COMPANY SNAPSHOT (2025) 412
FIGURE 51 CONDUENT INCORPORATED: COMPANY SNAPSHOT (2025) 415
FIGURE 52 HEALTHCARE BPO MARKET: RESEARCH DESIGN 433
FIGURE 53 DATA CAPTURED FROM SECONDARY SOURCES 435
FIGURE 54 PRIMARY INTERVIEW PARTICIPANTS 436
FIGURE 55 DATA CAPTURED FROM PRIMARY SOURCES 437
FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION,
AND REGION 437
FIGURE 57 CORE FINDINGS FROM INDUSTRY EXPERTS 438
FIGURE 58 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 439
FIGURE 59 HEALTHCARE BPO MARKET: BOTTOM-UP APPROACH 440
FIGURE 60 HEALTHCARE BPO MARKET: TOP-DOWN APPROACH 441
FIGURE 61 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 442
FIGURE 62 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 442
FIGURE 63 HEALTHCARE BPO MARKET: DATA TRIANGULATION 444

デジタルセラピューティクス（DTx）市場規模、シェア、動向、2031年までの世界予測前の記事ワクチン市場規模、シェア、動向、2031年までの世界予測次の記事

ヘルスケアBPO市場規模、シェア、動向、2031年までの世界予測